Anthony AggidisPhD student
Professor David Allsop’s research group, following extensive years of research have recently developed a novel retro-inverted peptide-based amyloid beta aggregation inhibitor that may be useful for treatment of Alzheimer’s disease. Tau aggregation inhibitors are a completely new venture for this research group. For my novel PhD research I am pioneering and developing peptide-based tau aggregation inhibitors, testing their interactions with a variety of tau protein aggregation systems and characterising subsequent structures formed from co-incubation. My successful lead tau aggregation inhibitor may be useful as a potential treatment for Alzheimer's disease and perhaps other tauopathies.
A novel approach to the therapy of Alzheimer's disease based on peptide nanoliposome inhibitors of Aβ and tau aggregation
Allsop, D., Taylor, M.N., Fullwood, N.J., Michael, M., Aggidis, A., Vincent, S., Dale, M. 1/11/2017
Investigating pipeline and state of the art blood glucose biosensors to formulate next steps
Aggidis, A., Newman, J.D., Aggidis, G. 15/12/2015 In: Biosensors and Bioelectronics. 74, p. 243-262. 20 p.